Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Crit Rev Oncol Hematol. 2012 Dec 23;86(2):97–103. doi: 10.1016/j.critrevonc.2012.11.008

Fig. 2. GOBO database: KDM3B, KDM5A and KDM6A expression related to prognosis in breast tumors.

Fig. 2

a. Low KDM3B expression is correlated with shorter RFS in LNneg tumors

b. Low and Intermediate KDM5A expression is correlated with shorter RFS in all tumors

c. Low KDM5A expression is correlated with shorter RFS in ER− tumors

d. High KDM6A expression is correlated with shorter OS in luminal A tumors

(RFS, Relapse free survival; LNneg, lymph node negative; ER−, estrogen receptor negative; OS, overall survival)